Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
67%(6 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_4
3
25%
Ph phase_2
1
8%
Ph not_applicable
8
67%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Terminated(2)
Other(1)

Detailed Status

Completed9
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 43 (25.0%)
N/A8 (66.7%)

Trials by Status

completed975%
terminated217%
unknown18%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_4

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

NCT02432404
completedphase_4

Acceptability of the NuvaRing Among Students

NCT00635570
unknownnot_applicable

A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

NCT02404038
completedphase_4

Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity

NCT02445989
completedphase_2

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

NCT01903031
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02432404Phase 4

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

Completed
NCT00635570Phase 4

Acceptability of the NuvaRing Among Students

Completed
NCT02404038Not Applicable

A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

Unknown
NCT02445989Phase 4

Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity

Completed
NCT01903031Phase 2

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

Completed
NCT00369967Not Applicable

Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

Terminated
NCT02529683Not Applicable

Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

Completed
NCT00710606Not Applicable

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Completed
NCT01298128Not Applicable

NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment

Terminated
NCT00374387Not Applicable

Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire

Completed
NCT01266759Not Applicable

Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia

Completed
NCT00565240Not Applicable

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

Completed

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12